These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 1845211)

  • 1. [Control of the treatment with oral anticoagulants and prothrombin time].
    Marzouka E
    Rev Med Chil; 1991 Oct; 119(10):1160-4. PubMed ID: 1845211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
    Gouin I; Horellou MH; Conard J; Samama M
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
    Loeliger EA; van den Besselaar AM; Lewis SM
    Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
    Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
    Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obtaining a reference pattern of rabbit brain thromboplastin].
    Martínez Placencia BM; Lanzetti Theiler MC; Córdova Caballero MS
    Rev Invest Clin; 1989; 41(3):247-52. PubMed ID: 2813999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of use of low international sensitivity index thromboplastins in prothrombin time testing.
    Ts'ao C; Swedlund J; Neofotistos D
    Arch Pathol Lab Med; 1994 Dec; 118(12):1183-7. PubMed ID: 7979911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality control of ISI/INR system in oral anticoagulant therapy].
    Kazama M
    Rinsho Ketsueki; 1990 Jun; 31(6):769-75. PubMed ID: 2214167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
    Guglielmone HA; Vides MA
    Ann Biol Clin (Paris); 1990; 48(8):547-50. PubMed ID: 2288441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prothrombin time and its standardization].
    Kagawa K
    Rinsho Byori; 2002 Aug; 50(8):779-85. PubMed ID: 12373814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of prothrombin time for laboratory control of oral anticoagulant therapy.
    Kitchen S; Preston FE
    Semin Thromb Hemost; 1999; 25(1):17-25. PubMed ID: 10327216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current biological surveillance of oral anticoagulant treatment].
    Helft G; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of oral anticoagulation. Current concepts].
    Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
    Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Standardization of the thromboplastin time determination].
    Dati F
    Z Med Lab Diagn; 1990; 31(4):211-24. PubMed ID: 2382469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J
    Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of thromboplastins using the ISI and INR system.
    Moriarty HT; Lam-Po-Tang PR; Anastas N
    Pathology; 1990 Apr; 22(2):71-6. PubMed ID: 2235100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Standardized prothrombin time determinations and optimal anticoagulant therapy].
    Jespersen J; Hansen MS; Dyerberg J; Ingerslev J; Jensen G; Jørgensen M; Laursen B; Nielsen JD; Svendsen TL
    Ugeskr Laeger; 1991 Jan; 153(5):355-60. PubMed ID: 1994562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
    Robert A; Chazouillères O
    Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.